AIM movers: Trakm8 fails to secure software contract and APQ NAV jump

Investment company APQ Global Ltd (LON: APQ) says book value was 23.87p/share at the end of February 2024, up from 6.02p/share at the end of 2023. This is based on the unaudited revaluation of private investments, particularly US-based Delphos International. At the end of June 2023, the Delphos International stake was valued at $6.26m. The share price jumped 175% to 5.5p.

Biodegradable and antimicrobial plastic additives developer Symphony Environmental Technologies (LON: SYM) has raised £1.4m at 3.5p/share and will raise up to £500,000 more through a PrimaryBid retail offer. The issue price was well above the market price, which has risen 42.86% to 3p. Chief executive Michael Laurier is subscribing £105,000. Net debt was £740,000 at the end of February. The additional cash will fund the scale-up of the business and provide working capital during trials by potential customers.

- Advertisement -

Forecasts for Intercede Group (LON: IGP) have been upgraded following an order for a new testing service for a US Federal Agency. This is the seventh upgrade by Cavendish in the past 12 months and it has raised its 2023-24 earnings expectations from 7.4p/share to 7.7p/share. However, profit is expected to be lower next year. The share price improved 13.1% to 112.5p.

Steel structures supplier Billington (LON: BILN) has revealed new orders worth £90m over 24 months. They are in a range of sectors including food, energy from waste and logistics. Margins are tight and the sector remains tough. This helps underpin the 2024 pre-tax profit forecast of £8m, which is a decline from the estimated 2023 figure of £13.3m, but it is well above the 2022 figure. The share price is one-eighth higher at 450p.


Fleet management technology provider Trakm8 Holdings (LON: TRAK) failed to secure the large software contract it was expecting in the year to March 2024. The contract could be signed later this year, but the 2023-24 forecast will not be met. Trading has also been weak in February and March due to lower insurance connections. Revenues of £16.4m are expected and a loss of £1.4m instead of the forecast pre-tax profit of £1.8m. Next year’s forecast will also be downgraded. The share price has slumped 35.7% to 9p.

- Advertisement -

Supercapacitors manufacturer Cap-XX (LON: CPX) has secured £2m from a placing and subscription at 0.1p/share ensuring that it does not run out of money. Cap-XX settled its patent litigation with Maxwell/Tesla ahead of the fundraising, but the terms are confidential. Up to £200,000 more can be raised through a REX retail offer. The offer closes at 3pm today. The share price declined by one-quarter to 0.1275p.

Kore Potash (LON: KP2) has raised $530,000 from a convertible loan note issue. They are convertible at 0.38p/share. The cash will be spent on further work on the Kola potash project. Chairman David Hathorn intends to subscribe $150,000 for shares after the 2023 results are published. The share price fell 14.3% to 0.45p.

Hutchmed (China) (LON: HCM) has started the registration stage of the phase II/III clinical trial of sovleplenib in adults with warm antibody autoimmune haemolytic anaemia in China. Positive trial results can be used for a New Drug Application. The share price dipped 4.17% to 264p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This

Tagdiv Cloud library - template content.